Net Income (Loss) Per Share |
Net Income (Loss) Per Share A reconciliation of net income (loss) available to common shareholders and the number of shares in the calculation of basic and diluted earnings (loss) income per share was calculated as follows: | | | | | | | | | | | | | | | | | | | For the Years Ended December 31, | (in thousands, except for share and per share amounts) | 2023 | | 2022 | | 2021 | Net income (loss) attributable to Privia Health Group, Inc. common stockholders | $ | 23,079 | | | $ | (8,585) | | | $ | (188,230) | | Weighted average common shares outstanding - basic | 116,731,406 | | | 110,695,266 | | | 102,952,370 | | | | | | | | Weighted average common share outstanding - diluted | 124,686,067 | | | 110,695,266 | | | 102,952,370 | | Earnings (loss) per share attributable to Privia Health Group, Inc. common stockholders – basic | $ | 0.20 | | | $ | (0.08) | | | $ | (1.83) | | Earnings (loss) per share attributable to Privia Health Group, Inc. common stockholders – diluted | $ | 0.19 | | | $ | (0.08) | | | $ | (1.83) | |
The treasury stock method is used to consider the effect of the potentially dilutive stock options. The following weighted-average outstanding shares of potentially dilutive securities were excluded from computation of diluted loss per share attributable to common shareholders for the period presented because including them would have been antidilutive: | | | | | | | | | | | | | | | | | | | For the Years Ended December 31, | | 2023 | | 2022 | | 2021 | Potentially dilutive stock options to purchase common stock, RSUs and PSUs | 5,589,224 | | | 15,581,385 | | | 20,901,103 | | Total potentially dilutive shares | 5,589,224 | | | 15,581,385 | | | 20,901,103 | |
|